Market Indices
Sector Heatmap
ORMP — Oramed Pharmaceuticals Inc.
NasdaqOramed Pharmaceuticals Inc.
- O
- 4.43
- H
- 4.45
- L
- 4.35
- V
- 84.72K
ORMP — Latest News & Headlines
9 StoriesA planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. - Stock Titan
A planned CFO sale at Oramed Pharmaceuticals (ORMP) totals 20,000 shares at an average $4.51. Stock Titan
An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. - Stock Titan
An officer proposes selling 20,000 Oramed (ORMP) shares under a preset trading plan. Stock Titan
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock - Investing.com
Oramed Pharmaceuticals CFO Avraham Gabay sells $90,200 in stock Investing.com
Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. - Stock Titan
Under a trading plan, Oramed (ORMP) COO Joshua Hexter sells 30,000 shares at $4.511 on average. Stock Titan
Oramed Pharmaceuticals stock fell 3.74 percent as targets rose - AD HOC NEWS
Oramed Pharmaceuticals stock fell 3.74 percent as targets rose AD HOC NEWS
40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. - Stock Titan
40% of Oramed (ORMP) CFO’s stock award vests at grant; the rest vests over 24 months. Stock Titan
Oramed officer proposes USD 140,100 sale of Oramed Pharmaceuticals stock - AD HOC NEWS
Oramed officer proposes USD 140,100 sale of Oramed Pharmaceuticals stock AD HOC NEWS
A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). - Stock Titan
A trading plan underpins an officer's proposed $140K share sale at Oramed (ORMP). Stock Titan
Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. - Stock Titan
Six option grants were canceled in exchange for a fully vested stock award to Oramed (ORMP) CEO Nadav Kidron. Stock Titan